Limitations of repurposing ceftazidime for : a cautionary perspective.
作者信息
Irulappan Madhumathi, Veeraraghavan Balaji
机构信息
Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
出版信息
mSphere. 2025 Aug 26;10(8):e0038425. doi: 10.1128/msphere.00384-25. Epub 2025 Aug 4.
Abstract
摘要
相似文献
1
Limitations of repurposing ceftazidime for : a cautionary perspective.将头孢他啶重新用于[具体用途]的局限性：一个警示性的观点。 （注：原文中“for”后面内容缺失）
mSphere. 2025 Aug 26;10(8):e0038425. doi: 10.1128/msphere.00384-25. Epub 2025 Aug 4.
2
Ceftazidime retains efficacy against strains of for which traditional testing predicts resistance.头孢他啶对传统检测预测为耐药的菌株仍保持疗效。
mSphere. 2025 Jun 25;10(6):e0084024. doi: 10.1128/msphere.00840-24. Epub 2025 May 22.
3
Reply to "Limitations of repurposing ceftazidime for : a cautionary perspective".对“将头孢他啶重新用于[具体用途]的局限性：警示性观点”的回复
mSphere. 2025 Aug 26;10(8):e0040425. doi: 10.1128/msphere.00404-25. Epub 2025 Aug 4.
4
Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone.嗜麦芽寡养单胞菌对头孢他啶-阿维巴坦联合用药与头孢他啶单药治疗的敏感性比较。
Med Mal Infect. 2020 May;50(3):305-307. doi: 10.1016/j.medmal.2020.01.003. Epub 2020 Jan 31.
5
Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.达托霉素和左氧氟沙星在模拟血浆和肺内 pH 值下对嗜麦芽窄食单胞菌的活性。
Microbiol Spectr. 2022 Aug 31;10(4):e0270521. doi: 10.1128/spectrum.02705-21. Epub 2022 Jul 11.
6
Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to .氨曲南加头孢他啶-阿维巴坦用于治疗由……引起的神经外科术后脑膜炎。 （原文此处病因未完整给出）
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0017225. doi: 10.1128/aac.00172-25. Epub 2025 Jun 2.
7
Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study.血液系统疾病中死亡率及从嗜麦芽窄食单胞菌定植进展为血流感染的预测因素：一项单中心回顾性研究
Eur J Clin Microbiol Infect Dis. 2025 Jul 25. doi: 10.1007/s10096-025-05217-2.
8
Hemorrhagic Pneumonia Caused by in Patients with Hematologic Malignancies-A Systematic Review and Meta-Analysis.血液系统恶性肿瘤患者感染导致的出血性肺炎：系统评价和荟萃分析。
Medicina (Kaunas). 2024 Jan 15;60(1):162. doi: 10.3390/medicina60010162.
9
Stenotrophomonas maltophilia endogenous endophthalmitis in an immunocompetent eye in Australia.澳大利亚一例免疫功能正常眼中的嗜麦芽窄食单胞菌内源性眼内炎
BMC Ophthalmol. 2025 Mar 28;25(1):158. doi: 10.1186/s12886-025-03990-4.
10
Genomic and machine learning approaches to predict antimicrobial resistance in .用于预测……中抗菌药物耐药性的基因组学和机器学习方法 。（原文句子不完整，“in”后面缺少具体内容）
Microbiol Spectr. 2025 Aug 5;13(8):e0263224. doi: 10.1128/spectrum.02632-24. Epub 2025 Jun 18.
引用本文的文献
1
Reply to "Limitations of repurposing ceftazidime for : a cautionary perspective".对“将头孢他啶重新用于[具体用途]的局限性：警示性观点”的回复
mSphere. 2025 Aug 26;10(8):e0040425. doi: 10.1128/msphere.00404-25. Epub 2025 Aug 4.
本文引用的文献
1
Ceftazidime retains efficacy against strains of for which traditional testing predicts resistance.头孢他啶对传统检测预测为耐药的菌株仍保持疗效。
mSphere. 2025 Jun 25;10(6):e0084024. doi: 10.1128/msphere.00840-24. Epub 2025 May 22.
2
Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing in Animal Infection Models: a Current State of Affairs.β-内酰胺类抗生素对动物感染模型中产金属β-内酰胺酶的活性：现状。
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02271-20.
3
Comparative Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against in the Murine Thigh Model.在小鼠大腿模型中，头孢地尔与人模拟暴露的头孢他啶对[具体对象未给出]的抗菌活性比较
Antimicrob Agents Chemother. 2019 Sep 9;63(12). doi: 10.1128/AAC.01558-19. Epub 2019 Oct 7.
4
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.理解和应对 CLSI 折点修订：临床实验室的入门指南。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00203-19. Print 2019 Jun.
5
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.肠杆菌科中静脉使用头孢菌素的折点——欧洲抗菌药物敏感性试验委员会（EUCAST）和美国临床和实验室标准协会（CLSI）的折点
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:169-74. doi: 10.1111/j.1469-0691.2007.01856.x.
Zotero 插件